You are the portfolio manager for a pharmaceutical company. The strategic plan prioritizes the development of new drugs for rare diseases. You are evaluating a proposed component: a research project for a new drug that targets a rare disease. The project has high potential but requires a significant investment in specialized laboratory equipment and personnel. The portfolio currently has three other drug development projects, two of which are in late-stage clinical trials. Which TWO actions should you take to ensure strategic alignment and effective portfolio management? (Choose two.)
The first step is to confirm that the project directly supports the strategic goal. If the drug targets a rare disease, it aligns with the strategic priority. This assessment ensures that the portfolio invests in components that advance the organization's strategy. Without this alignment check, resources might be allocated to projects that do not contribute to strategic objectives.
Why this answer
The portfolio manager should first confirm the project's alignment with the strategic goal of developing drugs for rare diseases, then conduct a capacity analysis to determine if the required specialized equipment and personnel can be secured. These steps ensure that the project is both strategically aligned and feasible within the portfolio's resource constraints.
Exam trap
The trap here is either approving the project without capacity analysis or rejecting it without assessing strategic alignment and capacity options.